Better Therapeutics Stock
Better develops prescription software for treating cardiometabolic diseases.
Sign up today and learn more about Better Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Better Therapeutics Stock
Better Therapeutics discovers, develops and commercializes prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases. We use clinically-validated, FDA-regulated software to change the behaviors that cause these diseases thereby improving quality of life, reducing the need for medications, and lowering costs. Our products deliver digital behavioral therapy that integrates neuroscience, lifestyle medicine, and explainable AI into a physician-prescribed mobile medical app, and uses patient-generated data to inform clinical decision-making and improve treatment outcomes. Our current product pipeline includes therapeutic candidates for the treatment of type 2 diabetes, hypertension, and dyslipidemia. Our founding team has started, led and exited multiple technology companies that have transformed industries and generated billions of dollars in enterprise value. The 17th Surgeon General of the US, Dr. Richard Carmona, serves as an independent board director. We were founded in 2015 and are headquartered in San Francisco, CA.
Kate Edwards, FNPC, MSN, RN
Co-Founder & CEO
Head of Clinical Operations
Contributing Editor / Interim Health Coach
Chief Medical Officer
Dr. Mark Berman
Chief Product Officer
Advisory Board Member / Senior Medical Advisor
Dr. David Eisenberg
Head of Engineering
Senior Health Coach